Related Experiment Videos
Achieving hypoxia-inducible gene expression in tumors
L Marignol1, M Lawler, Mary Coffey
1Department of Haematology and Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St. James's Hospital and Trinity College, Dublin, Ireland.
Cancer Biology & Therapy
|April 23, 2005
Summary
Solid tumors often feature hypoxia, hindering cancer treatment. Hypoxia-responsive elements (HREs) can selectively control gene expression, offering a promising strategy for hypoxia-mediated cancer gene therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Hypoxia, or low oxygen, is a hallmark of solid tumors and a primary driver of treatment resistance.
- Tumor hypoxia promotes genetic instability, apoptosis, and metastasis.
- Cellular adaptation to hypoxia involves regulating proteins controlling glucose metabolism, angiogenesis, vascular permeability, and inflammation.
Purpose of the Study:
- To investigate the potential of hypoxia-responsive elements (HREs) for targeted gene expression in hypoxic tumors.
- To explore hypoxia-mediated cancer gene therapy as a strategy to enhance conventional cancer treatments.
Main Methods:
- Identification and isolation of hypoxia-responsive element (HRE) sequences from oxygen-responsive genes.
- Placement of HRE sequences upstream of a promoter to drive gene expression.
- Evaluation of gene induction levels based on HRE copy number and oxygen tension.
Main Results:
- HRE sequences selectively induced gene expression in response to hypoxia.
- The degree of gene induction correlated with the number of HRE copies and the level of oxygen tension.
- Hypoxia-mediated gene expression modulation was demonstrated.
Conclusions:
- Hypoxia-responsive elements offer a mechanism for targeted gene expression in hypoxic tumor environments.
- Hypoxia-mediated cancer gene therapy presents a promising approach to augment the effectiveness of radiation and chemotherapy.
- Targeting tumor hypoxia through gene therapy could overcome treatment resistance and improve patient outcomes.